Predicting quality of life during lung cancer immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study uses a computer model to predict how immunotherapy for lung cancer may affect your quality of life. It aims to help doctors better manage side effects and improve your daily well-being during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer (confirmed by biopsy)
- You are 18 years or older
- You are currently receiving immunotherapy for your lung cancer
- You can communicate clearly (no severe hearing or speech problems)
- You or your family member can sign a consent form
- You do not have severe memory problems, thinking issues, or mental health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand the care needs of people with lung cancer who are receiving or have received immunotherapy. By participating, you can help improve support for other patients going through similar treatment.
This study looks at how patients with advanced lung cancer feel during their treatment, which combines chemotherapy, radiation, and an immunotherapy drug. The goal is to understand and improve quality of life during therapy.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
This study looks at whether certain biological markers can predict lung injury in people receiving both immunotherapy and radiation for lung cancer. The goal is to identify who might be at higher risk, so treatment can be tailored to reduce harm.
This study tests whether having regular check-ins on your quality of life (like symptoms and daily well-being) can help you feel better during lung cancer treatment. It's for patients recently diagnosed with lung cancer who are getting care at select hospitals in Bavaria.
This study looks at the physical and emotional needs of people with advanced cancer who are receiving immunotherapy. It aims to understand how these needs affect quality of life.
Hear when a new Lung Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.